Viewing Study NCT02489695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-05-20 @ 10:59 PM
Study NCT ID: NCT02489695
Status: COMPLETED
Last Update Posted: 2022-09-06
First Post: 2015-06-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
Sponsor: Centre Leon Berard
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Papillary Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None locally advanced or metastatic View